FACULTY
Evaluating New Developments for the Clinical Management of High Blood Cholesterol
Third in a Three Part Series: Proceedings from a Roundtable Symposium
Activity Date: September 2002  — Activity Info: Volume 2, (13)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity

 

CHAIRS

    Roger S. Blumenthal, MD
    Associate Professor of Medicine
    Johns Hopkins University School of Medicine
    Director of Preventive Cardiology
    The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease
    Johns Hopkins University School of Medicine
    Baltimore, Maryland
    • Dr Blumenthal reports receiving grants and/or research support from Merck, Pfizer, Wyeth-Ayerst, Bristol-Myers Squibb, and Novartis; and has received honoraria from Merck, Pfizer, Medcom, and Physician's World.

    Peter O. Kwiterovich, Jr, MD
    Professor of Medicine and Pediatrics
    Johns Hopkins University School of Medicine
    Director, Johns Hopkins University Lipid Clinic
    Chief, Lipid Research
    Johns Hopkins University Hospital
    Baltimore, Maryland
    • Dr Kwiterovich reports receiving grants and/or research support from AstraZeneca, Merck, Kos, and Pfizer; serving as a consultant to and receiving honoraria from Merck, Sankyo Pharma, and Kos.

PARTICIPATING FACULTY

    Bassem El-Masri, MD
    Assistant Professor of Clinical Medicine and Cardiology
    Director, Cardiac Prevention and Intervention Center
    Weill Medical College of Cornell University and New York Presbyterian Hospital
    New York, New York
    • Dr El-Masri reports serving as a consultant to Merck, Bristol-Myers Squibb, Pfizer, Novartis, GlaxoSmithKline, Sankyo, KOS, AstraZeneca, Bayer, Atherotec, and Lipomed; serving on the speakers bureau for KOS, GlaxoSmithKline, and Sankyo; and receiving grant/research support from Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Liposome, Merck, Novartis, and Schering-Plough.

    Sherita Hill Golden, MD, MHS
    Assistant Professor of Endocrinology
    Johns Hopkins University School of Medicine
    Baltimore, Maryland
    • Dr Golden reports receiving grants and/or research support from The Robert Wood Johnson Foundation.

    Howard Knapp, MD, PhD
    Executive Director
    Deaconess Billings Clinic
    Billings, Montana
    • Dr Knapp reports receiving grants and/or research support from Pfizer, Merck, Novartis, Knoll, Amgen, Bayer, Bristol-Myers Squibb, SmithKline Beecham, Pharmacia, Aventis, Wyeth-Ayerst, Schering-Plough, and Sankyo Pharma; and receiving honoraria from Roche, Bayer, and Sankyo Pharma.

    William C. Little, MD
    Chief, Cardiology Section
    Wake Forest University Baptist Medical Center
    Winston-Salem, North Carolina
    • Dr Little reports receiving grants and/or research support from Merck; and serving as a consultant to Merck and Sankyo.

    James J. Maciejko, MD, PhD
    Director of Preventive Cardiology
    St. Johns Hospital
    Detroit, Michigan
    • Dr Maciejko reports receiving grants and/or research support from Merck, Pfizer, Beckman-Coulter, and Roche; and receiving honoraria from Sankyo Pharma, Pfizer, Merck, Kos, DuPont, and Abbott.

    David G. Robertson, MD
    Assistant Clinical Professor
    Emory University School of Medicine
    Physician, Atlanta Diabetes Associates
    Atlanta, Georgia
    • Dr Robertson reports serving as a consultant for Kos and Abbott; and receiving honoraria from Pfizer, Bristol-Myers Squibb, and Sankyo Pharma.

Advanced Studies in Medicine provides disclosure information from contributing authors, lead presenters, and participating faculty. Advanced Studies in Medicine does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

     
Home | Contact Us | View Account | Need Help?